UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patient Preferences In Italy: Health State Utilities Associated With Attributes Of Weekly Injection Devices For Treatment Of Type 2 Diabetes

Value in health, 2017-10, Vol.20 (9), p.A591

2017

Volltextzugriff (PDF)

PMD105 - Patient Preferences In Italy: Health State Utilities Associated With Attributes Of Weekly Injection Devices For Treatment Of Type 2 Diabetes

Value in health, 2017-10, Vol.20 (9), p.A591-A591

2017

Volltextzugriff (PDF)

VALIDATION OF A QUESTIONNAIRE TO ASSESS PATIENT PERCEPTIONS OF INJECTION DEVICES FOR TYPE 2 DIABETES

Value in health, 2017-05, Vol.20 (5), p.A12

2017

Volltextzugriff (PDF)

Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors

Journal of medicinal chemistry, 2005-09, Vol.48 (19), p.6066-6083

2005

Volltextzugriff (PDF)

PRM168 - Survey of Neurologist’s Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure

Value in health, 2015-11, Vol.18 (7), p.A712-A712

2015

Volltextzugriff (PDF)

PMD109 - Health State Utilities Associated With Glucose Monitoring Devices

Value in health, 2015-11, Vol.18 (7), p.A363-A363

2015

Volltextzugriff (PDF)

PMD108 - Health State Utilities Associated With Attributes of Weekly Injection Devices for Treatment of Type 2 Diabetes

Value in health, 2015-11, Vol.18 (7), p.A363-A363

2015

Volltextzugriff (PDF)

Mutations Conferring Resistance to a Potent Hepatitis C Virus Serine Protease Inhibitor In Vitro

Antimicrobial Agents and Chemotherapy, 2004-06, Vol.48 (6), p.2260-2266

2004

Volltextzugriff (PDF)

Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro

Antimicrobial Agents and Chemotherapy, 2005-10, Vol.49 (10), p.4305-4314

2005

Volltextzugriff (PDF)

Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes

Patient preference and adherence, 2018-01, Vol.12, p.971-979

2018

Volltextzugriff (PDF)

PIN84 - Health State Utilities of Risks Associated with Antiretroviral Treatment for Human Immunodeficiency Virus (Hiv)

Value in health, 2015-11, Vol.18 (7), p.A590-A590

2015

Volltextzugriff (PDF)

Health State Utilities Associated With Glucose Monitoring Devices

Value in health, 2015-11, Vol.18 (7), p.A363-A363

2015

Volltextzugriff (PDF)

Survey of Neurologist’s Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure

Value in health, 2015-11, Vol.18 (7), p.A712-A712

2015

Volltextzugriff (PDF)

Health State Utilities Associated With Attributes of Weekly Injection Devices for Treatment of Type 2 Diabetes

Value in health, 2015-11, Vol.18 (7), p.A363-A363

2015

Volltextzugriff (PDF)

Health State Utilities of Risks Associated with Antiretroviral Treatment for Human Immunodeficiency Virus (Hiv)

Value in health, 2015-11, Vol.18 (7), p.A590-A590

2015

Volltextzugriff (PDF)

Influenza Neuraminidase Inhibitors: Structure-Based Design of a Novel Inhibitor Series

Biochemistry (Easton), 2003-01, Vol.42 (3), p.718-727

2003

Volltextzugriff (PDF)

Preference for pharmaceutical formulation and treatment process attributes

Patient preference and adherence, 2016-07, Vol.2016 (Issue 1), p.1385-1399

2016

Volltextzugriff (PDF)

Structure-Based Characterization and Optimization of Novel Hydrophobic Binding Interactions in a Series of Pyrrolidine Influenza Neuraminidase Inhibitors

Journal of medicinal chemistry, 2005-06, Vol.48 (12), p.3980-3990

2005

Volltextzugriff (PDF)

In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 1 Variants with Increased Resistance to ABT-378, a Novel Protease Inhibitor

Journal of Virology, 1998-09, Vol.72 (9), p.7532-7541

1998

Volltextzugriff (PDF)

X-ray crystallographic structure of ABT-378 (lopinavir) bound to HIV-1 protease

Bioorganic & medicinal chemistry, 2002-08, Vol.10 (8), p.2803-2806

2002

Volltextzugriff (PDF)

ABT-538 is a Potent Inhibitor of Human Immunodeficiency Virus Protease and has High Oral Bioavailability in Humans

Proceedings of the National Academy of Sciences - PNAS, 1995-03, Vol.92 (7), p.2484-2488

1995

Volltextzugriff (PDF)

Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction

Virology (New York, N.Y.), 2004-11, Vol.329 (2), p.319-327

2004

Volltextzugriff (PDF)

Reflection-mode x-ray powder diffraction cell for in situ studies of electrochemical reactions

Review of scientific instruments, 2004-05, Vol.75 (5), p.1251-1254

2004

Volltextzugriff (PDF)

In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675

Journal of Virology, 2002-06, Vol.76 (11), p.5380-5386

2002

Volltextzugriff (PDF)

1 – 25 von 286

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(245)

Publikationsform

Sprache

Englisch
(286)

Erscheinungsjahr

n.n

Thema

Science & Technology
(250)
Life Sciences & Biomedicine
(194)
Biological And Medical Sciences
(101)
Humans
(95)
Medical Sciences
(68)
Male
(65)
Female
(61)
Physical Sciences
(50)
Animals
(48)
Adult
(43)
Middle Aged
(36)
Technology
(34)
Fundamental And Applied Biological Sciences. Psychology
(33)
Pharmacology. Drug Treatments
(28)
Aged
(27)
Plant Sciences
(26)
Biochemistry & Molecular Biology
(23)
Chemistry
(23)
Exact Sciences And Technology
(22)
Pharmacology & Pharmacy
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Patient Preferences In Italy: Health State Utilities Associated With Attributes Of Weekly Injection Devices For Treatment Of Type 2 Diabetes

PMD105 - Patient Preferences In Italy: Health State Utilities Associated With Attributes Of Weekly Injection Devices For Treatment Of Type 2 Diabetes

VALIDATION OF A QUESTIONNAIRE TO ASSESS PATIENT PERCEPTIONS OF INJECTION DEVICES FOR TYPE 2 DIABETES

Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors

PRM168 - Survey of Neurologist’s Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure

PMD109 - Health State Utilities Associated With Glucose Monitoring Devices

PMD108 - Health State Utilities Associated With Attributes of Weekly Injection Devices for Treatment of Type 2 Diabetes

Mutations Conferring Resistance to a Potent Hepatitis C Virus Serine Protease Inhibitor In Vitro

Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro

Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes

Novel Transient Receptor Potential Vanilloid 1 Receptor Antagonists for the Treatment of Pain: Structure−Activity Relationships for Ureas with Quinoline, Isoquinoline, Quinazoline, Phthalazine, Quinoxaline, and Cinnoline Moieties

PIN84 - Health State Utilities of Risks Associated with Antiretroviral Treatment for Human Immunodeficiency Virus (Hiv)

Health State Utilities Associated With Glucose Monitoring Devices

Survey of Neurologist’s Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure

Health State Utilities Associated With Attributes of Weekly Injection Devices for Treatment of Type 2 Diabetes

Health State Utilities of Risks Associated with Antiretroviral Treatment for Human Immunodeficiency Virus (Hiv)

Influenza Neuraminidase Inhibitors: Structure-Based Design of a Novel Inhibitor Series

Preference for pharmaceutical formulation and treatment process attributes

Structure-Based Characterization and Optimization of Novel Hydrophobic Binding Interactions in a Series of Pyrrolidine Influenza Neuraminidase Inhibitors

In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 1 Variants with Increased Resistance to ABT-378, a Novel Protease Inhibitor

X-ray crystallographic structure of ABT-378 (lopinavir) bound to HIV-1 protease

ABT-538 is a Potent Inhibitor of Human Immunodeficiency Virus Protease and has High Oral Bioavailability in Humans

Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction

Reflection-mode x-ray powder diffraction cell for in situ studies of electrochemical reactions

In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675

Suchergebnisse filtern